Sopharma
ISIN BG11SOSOBT18
|WKN 157088
Overview
Description
Sopharma AD engages in the provision of pharmaceutical business. Its operations include production and marketing of medical products, medicinal substances as well as dosage forms. It also involved in research, engineering, and implementation activities in the field of phytochemistry, chemistry, and pharmacy. The firm offers dermatological products, gastroenterological, as well as psychoneurological, antiallergic and others. The company was founded in 1933 and is headquartered in Sofia, Bulgaria.
Healthcare Healthcare Services Healthcare Support Services Bulgaria
Financials
Key metrics
| Market capitalisation, EUR | 545.74 m |
| EPS, EUR | 0.38 |
| P/B ratio | 1.29 |
| P/E ratio | 8.18 |
| Dividend yield | 25.17% |
Income statement (2023)
| Revenue, EUR | 958.56 m |
| Net income, EUR | 48.69 m |
| Profit margin | 5.08% |
What ETF is Sopharma in?
There is 1 ETF which contains Sopharma.
| ETF | Weight | Investment focus | Holdings | TER | Fund size (in m EUR) | Return 1Y | WKN | ISIN |
|---|---|---|---|---|---|---|---|---|
| Expat Bulgaria SOFIX UCITS ETF | 19.51% | Equity Bulgaria | 10 | 1.30% | 4 | +30.43% | A2ARPV | BG9000011163 |
— Data provided by Trackinsight, etfinfo, Xignite Inc., gettex, FactSet and justETF GmbH. Quotes are either real-time (gettex) or 15 minutes delayed stock exchange quotes or NAVs (daily published by the fund provider). By default, ETF returns include dividend payments (if applicable). There is no warranty for completeness, accuracy and correctness for the displayed information.